Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 57

1.

FibroSURE as a noninvasive marker of liver fibrosis and inflammation in chronic hepatitis B.

Zeremski M, Dimova RB, Benjamin S, Makeyeva J, Yantiss RK, Gambarin-Gelwan M, Talal AH.

BMC Gastroenterol. 2014 Jul 3;14:118. doi: 10.1186/1471-230X-14-118.

PMID:
24990385
[PubMed - in process]
Free PMC Article
2.

Hepatitis C virus-related knowledge and willingness to receive treatment among patients on methadone maintenance.

Zeremski M, Dimova RB, Zavala R, Kritz S, Lin M, Smith BD, Zibbell JE, Talal AH.

J Addict Med. 2014 Jul-Aug;8(4):249-57. doi: 10.1097/ADM.0000000000000041.

PMID:
24820257
[PubMed - in process]
3.

Telaprevir-based treatment effects on hepatitis C virus in liver and blood.

Talal AH, Dimova RB, Zhang EZ, Jiang M, Penney MS, Sullivan JC, Botfield MC, Chakilam A, Sawant R, Cervini CM, Zeremski M, Jacobson IM, Kwong AD.

Hepatology. 2014 May 8. doi: 10.1002/hep.27202. [Epub ahead of print]

PMID:
24811404
[PubMed - as supplied by publisher]
4.

Editorial commentary: Management of hepatitis C Virus in HIV-infected patients in the era of direct-acting antivirals.

Zeremski M, Martinez AD, Talal AH.

Clin Infect Dis. 2014 Mar;58(6):880-2. doi: 10.1093/cid/cit804. Epub 2013 Dec 13. No abstract available.

PMID:
24336913
[PubMed - in process]
5.

Hepatitis C virus control among persons who inject drugs requires overcoming barriers to care.

Zeremski M, Zibbell JE, Martinez AD, Kritz S, Smith BD, Talal AH.

World J Gastroenterol. 2013 Nov 28;19(44):7846-51. doi: 10.3748/wjg.v19.i44.7846. Review.

PMID:
24307778
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Persistence of hepatitis C virus during and after otherwise clinically successful treatment of chronic hepatitis C with standard pegylated interferon α-2b and ribavirin therapy.

Chen AY, Zeremski M, Chauhan R, Jacobson IM, Talal AH, Michalak TI.

PLoS One. 2013 Nov 21;8(11):e80078. doi: 10.1371/journal.pone.0080078. eCollection 2013.

PMID:
24278242
[PubMed - in process]
Free PMC Article
7.

Depression and fatigue in chronic hepatitis C patients with and without HIV co-infection.

Tavakkoli M, Ferrando SJ, Rabkin J, Marks K, Talal AH.

Psychosomatics. 2013 Sep-Oct;54(5):466-71. doi: 10.1016/j.psym.2013.02.009. Epub 2013 Jun 4.

PMID:
23756122
[PubMed - indexed for MEDLINE]
8.

Cost-effectiveness of screening for chronic hepatitis C infection in the United States.

Eckman MH, Talal AH, Gordon SC, Schiff E, Sherman KE.

Clin Infect Dis. 2013 May;56(10):1382-93. doi: 10.1093/cid/cit069. Epub 2013 Feb 7.

PMID:
23392392
[PubMed - indexed for MEDLINE]
Free Article
9.

IL28B polymorphism, pretreatment CXCL10, and HCV RNA levels predict treatment response in racially diverse HIV/HCV coinfected and HCV monoinfected patients.

Zeremski M, Dimova RB, Makeyeva J, Sipley JD, Jacobson IM, Rennert H, Talal AH.

J Acquir Immune Defic Syndr. 2013 May 1;63(1):9-16. doi: 10.1097/QAI.0b013e31828323c1.

PMID:
23274935
[PubMed - indexed for MEDLINE]
10.

Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysis.

Dimova RB, Zeremski M, Jacobson IM, Hagan H, Des Jarlais DC, Talal AH.

Clin Infect Dis. 2013 Mar;56(6):806-16. doi: 10.1093/cid/cis1007. Epub 2012 Dec 7. Review.

PMID:
23223596
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Unique and differential protein signatures within the mononuclear cells of HIV-1 and HCV mono-infected and co-infected patients.

Boukli NM, Shetty V, Cubano L, Ricaurte M, Coelho-Dos-Reis J, Nickens Z, Shah P, Talal AH, Philip R, Jain P.

Clin Proteomics. 2012 Sep 7;9(1):11. doi: 10.1186/1559-0275-9-11.

PMID:
22958358
[PubMed]
Free PMC Article
12.

Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection.

Patin E, Kutalik Z, Guergnon J, Bibert S, Nalpas B, Jouanguy E, Munteanu M, Bousquet L, Argiro L, Halfon P, Boland A, Müllhaupt B, Semela D, Dufour JF, Heim MH, Moradpour D, Cerny A, Malinverni R, Hirsch H, Martinetti G, Suppiah V, Stewart G, Booth DR, George J, Casanova JL, Bréchot C, Rice CM, Talal AH, Jacobson IM, Bourlière M, Theodorou I, Poynard T, Negro F, Pol S, Bochud PY, Abel L; Swiss Hepatitis C Cohort Study Group; International Hepatitis C Genetics Consortium; French ANRS HC EP 26 Genoscan Study Group.

Gastroenterology. 2012 Nov;143(5):1244-52.e1-12. doi: 10.1053/j.gastro.2012.07.097. Epub 2012 Jul 27.

PMID:
22841784
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Assessment of methadone clinic staff attitudes toward hepatitis C evaluation and treatment.

Talal AH, Dimova RB, Seewald R, Peterson RH, Zeremski M, Perlman DC, Des Jarlais DC.

J Subst Abuse Treat. 2013 Jan;44(1):115-9. doi: 10.1016/j.jsat.2012.01.010. Epub 2012 Mar 8.

PMID:
22405884
[PubMed - indexed for MEDLINE]
14.

Randomized trial comparing dose reduction and growth factor supplementation for management of hematological side effects in HIV/hepatitis C virus patients receiving pegylated-interferon and ribavirin.

Talal AH, Liu RC, Zeremski M, Dimova R, Dove L, Pearce D, Hassanein T, Doonquah L, Aboulafia D, Rodriguez J, Bonilla H, Galpin J, Aberg JA, Johnston B, Glesby MJ, Jacobson IM.

J Acquir Immune Defic Syndr. 2011 Nov 1;58(3):261-8. doi: 10.1097/QAI.0b013e3182324af9.

PMID:
21876446
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

CXCL9 and CXCL10 chemokines as predictors of liver fibrosis in a cohort of primarily African-American injection drug users with chronic hepatitis C.

Zeremski M, Dimova R, Astemborski J, Thomas DL, Talal AH.

J Infect Dis. 2011 Sep 15;204(6):832-6. doi: 10.1093/infdis/jir424.

PMID:
21849280
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Hepatitis C virus infection in USA: an estimate of true prevalence.

Chak E, Talal AH, Sherman KE, Schiff ER, Saab S.

Liver Int. 2011 Sep;31(8):1090-101. doi: 10.1111/j.1478-3231.2011.02494.x. Epub 2011 Mar 16. Review.

PMID:
21745274
[PubMed - indexed for MEDLINE]
17.

Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset.

Charles ED, Brunetti C, Marukian S, Ritola KD, Talal AH, Marks K, Jacobson IM, Rice CM, Dustin LB.

Blood. 2011 May 19;117(20):5425-37. doi: 10.1182/blood-2010-10-312942. Epub 2011 Mar 18.

PMID:
21421840
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Quality of care in patients with chronic hepatitis C virus infection.

Talal AH, Perlman DC, Des Jarlais DC.

Ann Intern Med. 2011 Feb 1;154(3):213-4; author reply 214-5. doi: 10.7326/0003-4819-154-3-201102010-00018. No abstract available.

PMID:
21282706
[PubMed - indexed for MEDLINE]
19.

Induction of CXCR3- and CCR5-associated chemokines during acute hepatitis C virus infection.

Zeremski M, Hooker G, Shu MA, Winkelstein E, Brown Q, Des Jarlais DC, Tobler LH, Rehermann B, Busch MP, Edlin BR, Talal AH.

J Hepatol. 2011 Sep;55(3):545-53. doi: 10.1016/j.jhep.2010.12.033. Epub 2011 Jan 21.

PMID:
21256906
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Insulin resistance predicts re-treatment failure in an efficacy study of peginterferon-α-2a and ribavirin in HIV/HCV co-infected patients.

Vachon ML, Factor SH, Branch AD, Fiel MI, Rodriguez-Torres M, Bräu N, Sterling RK, Slim J, Talal AH, Dieterich DT, Sulkowski MS.

J Hepatol. 2011 Jan;54(1):41-7. doi: 10.1016/j.jhep.2010.06.025. Epub 2010 Aug 21.

PMID:
20974502
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk